Article Information
History
- March 31, 2021.
Article Versions
- Version 1 (March 26, 2021 - 11:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fredy Suter, MD1,
- Elena Consolaro, MD2,
- Stefania Pedroni, MD2,
- Chiara Moroni, MD2,
- Elena Pastò, MD2,
- Maria Vittoria Paganini, MD2,
- Grazia Pravettoni, MD3,
- Umberto Cantarelli, MD4,
- Nadia Rubis, Res Nurse5,
- Norberto Perico, MD*,5,&,
- Annalisa Perna, MSC5,
- Tobia Peracchi, StatScid5,
- Piero Ruggenenti, MD*,1,5 and
- Giuseppe Remuzzi, MD*,5
- 1Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy
- 2ATS Insubria, Varese, Italy
- 3Ospedale Circolo di Busto Arsizio, Varese, Italy
- 4ASL Teramo, Teramo, Italy
- 5Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
- ↵&Correspondence to: Norberto Perico MD, Istituto di Ricerche Farmacologiche IRCCS, Centro di Ricerche Cliniche per Malattie Rare Aldo e Cele Daccò, Via GB Camozzi 3, 24020 Ranica, Bergamo, Italy. Email: norberto.perico{at}marionegri.it